RadNet's Quantib B.V. Subsidiary Receives FDA Clearance for
LOS ANGELES, May 01, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc., (NASDAQ: RDNT) today announced that it has received FDA clearance for the third-generation...
Stay updated with breaking news from Quantib Prostate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LOS ANGELES, May 01, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc., (NASDAQ: RDNT) today announced that it has received FDA clearance for the third-generation...
01.05.2023 - LOS ANGELES, May 01, 2023 (GLOBE NEWSWIRE) - RadNet, Inc., (NASDAQ: RDNT) today announced that it has received FDA clearance for the third-generation release of its Quantib Prostate 3.0 MRI artificial intelligence (AI) software, further enhancing ... Seite 1
By Stephen Nakrosis RadNet Inc. on Monday said its Quantib B.V. subsidiary received 510 clearance from the Food and Drug Administration for the third-generation release of its Quantib Prostate... | May 1, 2023